亚太地区医疗灌注技术市场预测至 2027 年 - COVID-19 影响和按技术（低温机器灌注和常温机器灌注）、器官类型（心脏、肺、肾、肝脏等）进行的区域分析；组件（灌注泵、氧合器、心肺机、监测系统、插管等）
No. of Pages: 122 | Report Code: TIPRE00021069 | Category: Life Sciences
No. of Pages: 122 | Report Code: TIPRE00021069 | Category: Life Sciences
灌注是指液体通过循环系统或淋巴系统到达器官或组织，通常指的是将血液输送到组织中的毛细血管床。灌注测量为血液输送到组织的速率，或每单位组织质量每单位时间的血液量（血流量）。在大型手术期间，灌注必须由相关医疗专业人员维持和管理，而不是仅仅依靠身体的稳态。
亚太地区医疗灌注技术市场预计将从 2019 年的 1.486 亿美元增至 2027 年的 2.123 亿美元。预计该市场将以复合年增长率增长2020 年至 2027 年期间将增长 4.7%。由于心血管疾病患病率上升和器官移植实践的增加等关键驱动因素，预计该市场的增长将会增长。然而，由于器官移植手术费用昂贵，预计市场在预测期内增长缓慢。
根据技术，医疗灌注技术市场分为低温机器灌注和常温机器灌注。根据器官类型，医疗灌注技术市场分为心脏、肺、肾、肝脏等。根据组件，医疗灌注技术市场分为灌注泵、氧合器、心肺机、监测系统、插管等。
报告中包含医疗灌注技术市场的一些主要一手和二手来源世界卫生组织 (WHO)、CFDA（中国食品药品监督管理局）等。
按技术
按器官类型
按成分
按国家/地区
Strategic insights for Asia Pacific Medical Perfusion Technology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 148.6 Million |
| Market Size by 2027 | US$ 212.3 Million |
| Global CAGR (2020 - 2027) | 4.7% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Medical Perfusion Technology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Medical Perfusion Technology Market is valued at US$ 148.6 Million in 2019, it is projected to reach US$ 212.3 Million by 2027.
As per our report Asia Pacific Medical Perfusion Technology Market, the market size is valued at US$ 148.6 Million in 2019, projecting it to reach US$ 212.3 Million by 2027. This translates to a CAGR of approximately 4.7% during the forecast period.
The Asia Pacific Medical Perfusion Technology Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Medical Perfusion Technology Market report:
The Asia Pacific Medical Perfusion Technology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Medical Perfusion Technology Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Medical Perfusion Technology Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Medical Perfusion Technology Market
